Abstract
Akathisia as well as younger age, early illness onset and discharge are important risk factors for suicidality in patients with first-episode schizophrenia. The aim of the present study was to analyze on a single case basis the relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician- and patient-rated akathisia. A small subsample of patients demonstrated a positive relationship between suicidality and akathisia scores within the titration period of the study medication.
© Georg Thieme Verlag KG Stuttgart · New York.
Publication types
-
Case Reports
-
Clinical Trial
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Akathisia, Drug-Induced / psychology*
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use
-
Anxiety / chemically induced
-
Female
-
Haloperidol / adverse effects*
-
Haloperidol / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Psychiatric Status Rating Scales / statistics & numerical data
-
Risk Factors
-
Risperidone / adverse effects*
-
Risperidone / therapeutic use
-
Schizophrenia / drug therapy*
-
Schizophrenic Psychology*
-
Suicidal Ideation*
Substances
-
Antipsychotic Agents
-
Haloperidol
-
Risperidone